2023 Approvals

FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

What is Elrexfio prescribed for?   Elrexfio is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Elrexfio, pronounced el-reks-fe-o, (generic name: elranatamab-bcmm). It is a prescription medication approved for...

FDA Approves Talvey for Multiple Myeloma on August 9, 2023

FDA Approves Talvey for Multiple Myeloma on August 9, 2023

What is Talvey prescribed for?   Talvey is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Talvey, pronounced tal vay, (generic name: talquetamab-tgvs). It is a prescription medication approved to treat adults...

FDA Approves Izervay for Treating Severe  Age-related Macular Degeneration August 4, 2023

FDA Approves Izervay for Treating Severe  Age-related Macular Degeneration August 4, 2023

What is Izervay prescribed for?   Izervay is prescribed to treat geographic atrophy (GA) secondary to age-related macular degeneration. What is the name of the drug and what does it do? Izervay, pronounced  EYE-ZER-VEY, (generic name: avacincaptad pegol) is a prescription medication approved for the treatment of geographic atrophy (GA), which is a...

FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023

FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023

What is XDEMVY prescribed for?   XDEMVY is prescribed to treat a parasitic infection of the eye (Demodex blepharitis) that can  especially affect the eyelids. What is the name of the drug and what does it do? XDEMVY, pronounced X-DEM-VEE, (generic name: lotilaner)  is a prescription medication approved for the treatment of Demodex blepharitis, a...

FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023

FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023

What is Leqembi prescribed for?   Leqembi is prescribed to treat Alzheimer’s disease for people in the early stages of the disease. What is the name of the drug and what does it do?  The U.S. Food and Drug Administration has approved Leqembi (generic name: lecanemab-irmb), pronounced “leh-kem’-bee,” for the treatment of Alzheimer's disease. ...

FDA Expands Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy: June 2023

FDA Expands Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy: June 2023

What is Elevidys prescribed for?   To treat Duchenne muscular dystrophy (DMD) in patients who are 4 years of age and older and have a confirmed mutation in the DMD gene. What is the name of the drug and what does it do?  Elevidys (generic name: delandistrogene moxeparvovec-rokl), pronounced "el-eh-vid-iss," is a special treatment approved by the U.S....